Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  New England Journal of Medicine

• Publication date

  1996-06-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199606133342401PMID 8628335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

  2005cited by this paper
• Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.

  1994cited by this paper
• Prediction of relapse in patients with Crohn's disease in remission: a simplified index using laboratory tests, enhanced by clinical characteristics

  1994cited by this paper
• Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients

  1994cited by this paper
• Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats.

  1994cited by this paper
• Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.

  1993cited by this paper
• Thrornboxanes in inflammatory bowel disease—pathogenic and therapeutic implications

  1993cited by this paper
• Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.

  1993cited by this paper
• Thromboembolism in inflammatory bowel disease: role of platelets.

  1993cited by this paper
• Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

  1993cited by this paper
• Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

  1992cited by this paper
• Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

  1992cited by this paper
• Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.

  1992cited by this paper
• A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty.

  1992cited by this paper
• Dietary Supplementation with Fish Oil in Ulcerative Colitis

  1992cited by this paper
• Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group.

  1992cited by this paper
• Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients.

  1992cited by this paper
• Decreased responsiveness of platelets to a stable prostacyclin analogue in patients with Crohn's disease. Reversal by n-3 polyunsaturated fatty acids.

  1991cited by this paper
• Intrahepatic cholesterol stones: a rationale for dissolution therapy.

  1991cited by this paper
• Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease

  1990cited by this paper
• Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

  1989cited by this paper
• Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind cross‐over trial

  1989cited by this paper
• The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

  1989cited by this paper
• Applied Logistic Regression, Second Edition

  1989cited by this paper
• Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters.

  1988cited by this paper
• Predictors of acute relapse of Crohn's disease

  1987cited by this paper
• Enteral absorption in man of eicosapentaenoic acid in different chemical forms

  1987cited by this paper
• Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function.

  1986cited by this paper
• A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.

  1986cited by this paper
• Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential

  1986cited by this paper
• Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

  1985cited by this paper
• Inhibition of platelet function by cis-unsaturated fatty acids.

  1984cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper

• Genome-wide Mendelian randomization implicates metabolism-related gene expression in inflammatory bowel disease in European populations.

  2026cites this paper
• No causal relationship between polyunsaturated fatty acids and inflammatory bowel disease: A Mendelian randomization study.

  2025cites this paper
• Molecular Features, Effective Sources, and Physiological Effects of Omega-3 Unsaturated Fatty Acids on Cardiovascular, Neurological, and Muscular Health, and Clinical Relevance for Several Conditions: A Narrative Review.

  2025cites this paper
• Synthesis and Characterization of Poly(N-Acryloyl 6-Aminocaproic Acid) for Intestine-Specific Drug Delivery

  2025cites this paper
• Antioxidative Action of Alpha-Linolenic Acid during Its Gastroprotective Effect in an Indomethacin-Induced Gastric Injury Model

  2025cites this paper
• Parenteral n-3 polyunsaturated fatty acids supplementation improves postoperative recovery for patients with Crohn's disease after bowel resection: a randomized, unblinded controlled clinical trial.

  2024cites this paper
• Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study

  2023cites this paper
• A primer on common supplements and dietary measures used by patients with inflammatory bowel disease

  2023cites this paper
• Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.

  2023cites this paper
• A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive Review

  2023cites this paper
• Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids

  2023cites this paper
• Dietary supplements for intestinal inflammation

  2022cites this paper
• The metabolic nature of inflammatory bowel diseases

  2022cites this paper
• Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats.

  2022cites this paper
• Soil health and nutrient density: preliminary comparison of regenerative and conventional farming

  2022cites this paper
• PUFA-induced metabolic enteritis as a fuel for Crohn's disease.

  2022cites this paper
• A pilot randomized controlled trial testing supplements of omega-3 fatty acids, probiotics, combination or placebo on symptoms of depression, anxiety and stress

  2021cites this paper
• Antiinflammatory natural products from marine algae

  2021cites this paper
• Influences of dietary oils and fats, and the accompanied minor content of components on the gut microbiota and gut inflammation: A review

  2021cites this paper
• Role of diet and nutrition in inflammatory bowel disease

  2021cites this paper
• Docosahexaenoic acid in the treatment of male infertility caused by high sperm DNA fragmentation

  2021cites this paper
• Fish Oil for Inflammatory Bowel Disease: Panacea or Placebo?

  2021cites this paper
• Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs)

  2021cites this paper
• A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease

  2021cites this paper
• Nutraceuticals in gastrointestinal disorders

  2021cites this paper
• Significance of serum palmitoleic acid levels in inflammatory bowel disease

  2021cites this paper
• Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease

  2020cites this paper
• Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease

  2020cites this paper
• A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease.

  2020cites this paper
• Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing.

  2020cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2020cites this paper
• Nutrition, IBD and Gut Microbiota: A Review

  2020cites this paper
• A novel eicosapentaenoic acid-derived anti-inflammatory lipid mediator 5,6-DiHETE is abundant in blue back fish intestines.

  2020cites this paper
• Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis)

  2020cites this paper
• The Protective Effect of Omega3 Against Amikacin- Induced Nephrotoxicity in Rats

  2020cites this paper
• Bénéfices et risques des compléments alimentaires

  2020cites this paper
• Customized Prevention Trials Could Resolve the Controversy of the Effects of Omega-3 Fatty Acids on Cancer

  2020cites this paper
• Nutrition and gastrointestinal disorders

  2020cites this paper
• Beyond cardiovascular medicine: potential future uses of icosapent ethyl

  2020cites this paper
• Controversies about the cardiovascular effects of OM3FA. Did inappropriate placebos skew clinical trial results?

  2020cites this paper
• Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials

  2020cites this paper
• Omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis: an updated meta-analysis

  2020cites this paper
• Nutrition in Inflammatory Bowel Disease

  2020cites this paper
• Nutritional and Health Benefits of Seafoods

  2020cites this paper
• Lego-inspired capsular devices for the development of personalized dietary supplements: proof of concept with multimodal release of caffeine.

  2020cites this paper
• Fish oil reduced relapse and maintained remission in Crohn disease

  2020cites this paper
• Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer

  2020cites this paper
• Omega-3 polyunsaturated fatty acids attenuate inflammatory activation and alter differentiation in human adipocytes.

  2019cites this paper
• Systematic review: outcomes and adverse events from randomised trials in Crohns disease

  2019cites this paper
• Redox modulatory protective effects of ω-3 fatty acids rich fish oil against experimental colitis

  2019cites this paper
• Cognitive and emotional health

  2019cites this paper
• Nutrition anti-inflammatoire et MICI : que dire à nos patients ?

  2019cites this paper
• Systematic review: outcomes and adverse events from randomised trials in Crohn's disease

  2019cites this paper
• G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2.

  2019cites this paper
• Therapy for Crohn's Disease

  2019cites this paper
• Diet, Inflammation, Gut Microbiome, and Mental Health

  2019cites this paper
• Omega-3 Fatty Acids (Prong-1)

  2019cites this paper
• Crohn's disease.

  2019cites this paper
• A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease

  2019cites this paper
• Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

  2019cites this paper
• Inflammatory bowel disease.

  2019cites this paper
• Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance

  2019influential citation
• Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD

  2019cites this paper
• Treating Inflammatory Bowel Disease With Diet: A Taste Test.

  2019cites this paper
• Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study

  2019cites this paper
• Hierarchically structured phase separated biopolymer hydrogels create tailorable delayed burst release during gastrointestinal digestion.

  2019cites this paper
• Utilization of marine by-products for the recovery of value-added products

  2019cites this paper
• Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System

  2019cites this paper
• De novo transcriptome assembly of the eight major organs of Sacha Inchi (Plukenetia volubilis) and the identification of genes involved in α-linolenic acid metabolism

  2018cites this paper
• Dietary practices and inflammatory bowel disease

  2018cites this paper
• Inflammation and intestinal leakiness in older HIV+ individuals with fish oil treatment

  2018cites this paper
• EPA blocks TNF‐α‐induced inhibition of sugar uptake in Caco‐2 cells via GPR120 and AMPK

  2018cites this paper
• Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists

  2018cites this paper
• Current scenario of Canadian fishery and corresponding underutilized species and fishery byproducts: A potential source of omega-3 fatty acids

  2018cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2018cites this paper
• ENFERMEDAD INFLAMATORIA INTESTINAL

  2018cites this paper
• Docosahexaenoic acid in the treatment of male infertility

  2018cites this paper
• Effects of Fish Oil on HIV-Related Inflammation and Markers of Immunosenescence: A Randomized Clinical Trial

  2018cites this paper
• An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets

  2018cites this paper
• Effect of dietary omega-3 supplementation on plasma phospholipids, neutral lipids fatty acids and antioxidant status of pregnant women with gestational diabetes and their neonates

  2018cites this paper
• Cost-effectiveness modelling for benefit-risk assessment

  2018cites this paper
• Effects of Omega‐3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue

  2018cites this paper
• Production of lipid mediators across different disease stages of dextran sodium sulfate-induced colitis in mice[S]

  2018cites this paper
• The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease

  2018cites this paper
• Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial

  2018cites this paper
• Alpha-Linolenic Acid Supplementation is Associated with Changes in Inflammatory Markers and Endoplasmic Reticulum Stress in Diabetic Rats

  2018cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2018cites this paper
• From metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn’s disease

  2018cites this paper
• The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

  2018cites this paper
• N-3 polyunsaturated fatty acids intake and serum fatty acid levels in patients with Crohn's Disease : Comparison with ulcerative colitis patients : ASPEN (American Society for Parenteral and Enteral Nutrition) 2017 Nutrition Science & Practice Conference in Orlando, USA

  2018cites this paper
• Application of Food By‐Products in Medical and Pharmaceutical Industries

  2017cites this paper
• PUFAs and IBD: Is There a Relationship?

  2017cites this paper
• Constitutive ω-3 fatty acid production in fat-1 transgenic mice and docosahexaenoic acid administration to wild type mice protect against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.

  2017cites this paper
• The Practical Pros and Cons of Complementary and Alternative Medicine in Practice: Integrating Complementary and Alternative Medicine into Clinical Care.

  2017cites this paper
• Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease

  2017cites this paper
• Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination.

  2017cites this paper
• From metagenomic data to personalized computational microbiotas: Predicting dietary supplements for Crohn's disease

  2017cites this paper
• The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives

  2017cites this paper
• Effet protecteur des acides gras polyinsaturés n-3 sur la neuroinflammation : implication des dérivés lipidiques

  2017cites this paper
• Glutathione Dysregulation, Cardiac Oxidative Stress, and Inflammation during n-6 Polyunsaturated Fatty Acid Overload

  2017cites this paper